| Literature DB >> 31849690 |
Zihan Xu1, Wenjun Ding2, Xiaobei Deng1.
Abstract
Epithelial-mesenchymal transition (EMT) refers to the conversion of epithelial cells to mesenchymal phenotype, which endows the epithelial cells with enhanced migration, invasion, and extracellular matrix production abilities. These characteristics link EMT with the pathogenesis of organ fibrosis and cancer progression. Recent studies have preliminarily established that fine particulate matter with an aerodynamic diameter of less than 2.5 μm (PM2.5) is correlated with EMT initiation. In this pathological process, PM2.5 particles, excessive reactive oxygen species (ROS) derived from PM2.5, and certain components in PM2.5, such as ions and polyaromatic hydrocarbons (PAHs), have been implicated as potential EMT mediators that are linked to the activation of transforming growth factor β (TGF-β)/SMADs, NF-κB, growth factor (GF)/extracellular signal-regulated protein kinase (ERK), GF/phosphatidylinositol 3-kinase (PI3K)/Akt, wingless/integrated (Wnt)/β-catenin, Notch, Hedgehog, high mobility group box B1 (HMGB1)-receptor for advanced glycation end-products (RAGE), and aryl hydrocarbon receptor (AHR) signaling cascades and to cytoskeleton rearrangement. These pathways directly and indirectly transduce pro-EMT signals that regulate EMT-related gene expression in epithelial cells, finally inducing the characteristic alterations in morphology and functions of epithelia. In addition, novel associations between autophagy, ATP citrate lyase (ACLY), and exosomes with PM2.5-induced EMT have also been summarized. However, some debates and paradoxes remain to be consolidated. This review discusses the potential molecular mechanisms underlying PM2.5-induced EMT, which might account for the latent role of PM2.5 in cancer progression and fibrogenesis.Entities:
Keywords: PM2.5; air pollution; cancer; environment and human health; epithelial-mesenchymal transition; fibrosis; molecular toxicology; signaling pathway
Year: 2019 PMID: 31849690 PMCID: PMC6896848 DOI: 10.3389/fphys.2019.01404
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Positive transcriptional regulation among pro-EMT transcription factors.
| Transcriptional inducers | Effectors | Reference |
|---|---|---|
| Snail | Slug | |
| Twist | ||
| ZEB1 | ||
| ZEB2 | ||
| LEF-1 | ||
| LEF-1 | Slug | |
| Twist | Slug | |
| ZEB1 | ||
| TCF-4 | ZEB1 | |
| HMGA2 | Snail | |
| Slug | ||
| Twist | ||
| NF-κB | Snail | |
| Slug | ||
| ZEB1 | ||
| ZEB2 |
EMT, epithelial-mesenchymal transition.
Figure 1Brief schema of the putative signaling transduction mechanisms underlying EMT. Activation of the Wnt/β-catenin, PI3K/Akt, Ras/ERK, TGF-β/SMAD2/3, BMP/SMAD1/5/8, JAK/STAT3, Shh, and Notch pathways is highly correlated with EMT. After ligand-receptor binding, intracellular secondary messengers are activated and initiated downstream transduction, which generally induce the nuclear translocation of signaling-specific TFs and the transcriptional regulation of EMT-related genes, such as CDH1 and CDH2, EMT TFs, and mesenchymal markers, accompanied by a series of alterations on cellular physiological or pathological activities (e.g., disjunction of adherin junctions, cytoskeleton remodeling, and increase of cellular motility). Arrows represent the molecular interactions in which downstream messengers are activated; T shape arrows represent inhibitive molecular interactions. EMT, epithelial-mesenchymal transition; PI3K, phosphoinositide 3-kinase; ERK, extracellular signal-regulated protein kinase; TGF-β, transforming growth factor β; JAK, Janus kinase; Shh, sonic hedgehog; TFs, transcription factors.
Summary table about exposure assays of some studies reviewed in section “Potential Reactive Oxygen Species-Dependent Mechanisms in PM2.5-Induced Epithelial-Mesenchymal Transition.”
| Source of PM2.5 | Dose of PM2.5 exposure | Duration of exposure | Cell type | Antioxidant | Dose of antioxidant | Reference |
|---|---|---|---|---|---|---|
| Collected at Atlanta, USA, from March 1, 2004 to June 30, 2004 using Teflon filter | 0.1, 1, 10 μg/cm2 | 5 days | Rat alveolar type II epithelial cell line (RLE-6TN cells) | 5 μmol/L | ||
| Collected at Beijing, China, from January 19, 2015 to January 21, 2015 using 90-mm Emfab filter | 1, 5, 30 μg/cm2 | Single exposure: 1 day | Human bronchial epithelial cell line (BEAS-2B cells) | NAC | 100 μmol/L | |
| Collected at Changchun, China, from November 2015 to March 2016 using quartz filter | 25 μg/cm2 | 1, 6, 12, 24 h | Human bronchial epithelial cell line (BEAS-2B cells) | NAC | 5 μmol/L | |
| Ni ions were bought from Sigma, USA | Ni2+: 0.4 μmol/L | 24 h | Human lung cancer cell line (A549 cells) | NAC | 5 mmol/L | |
| Collected at Guangzhou, China, using quartz filter | 20, 50, 100 μg/ml | 24 h | Human corneal epithelial cell line (HCEC cells) | NAC | 1 mg/ml | |
| Bought from National Institute of Standards and Technology (NIST), USA (the product label: SRM 2786) | 2.5, 5, 10 μg/ml | 24 h | Human hepatic stellate cell line (LX-2 cells) | NAC | 1 mmol/L | |
| Collected at Beijing, China, from January 2009 to June 2009 using nitrocellulose filter | 8, 16, 32, 64 μg/cm2 | 12, 24, 48 h | Human lung cancer cell line (A549 cells) | NAC | 5 mmol/L |
Summary table about exposure assays of some studies reviewed in section “Other Molecular Events Underlying PM2.5-Induced Epithelial-Mesenchymal Transition.”
| Source of PM2.5 for treatment | Dose of PM2.5 exposure | Duration of exposure | Cell type | Reference |
|---|---|---|---|---|
| Collected at Beijing, China, from December 2016 to February 2017 using glass fiber filter | 25, 50, 100 μg/ml | Chronic exposure for 5 passages | Human lung cancer cell line (A549 cells) | |
| Collected at Shenyang, China, in winter using nitrocellulose filter | 5, 10, 20 μg/cm2 | 72 h | Human lung cancer cell line (A549 cells) | |
| Collected at Shanghai, China, from November 2017 to June 2018 using glass fiber filter | 50 μg/mL | Chronic exposure for 30 passages | Human bronchial epithelial cell line (BEAS-2B cells) | |
| Bought from NIST, USA (the product label: SRM 1648a) | 100, 500 μg/ml | Chronic exposure for 30 passages | Human bronchial epithelial cell line (HBE cells) | |
| Collected at Nanjing and Shanghai, China, in Autumn 2014 using quartz filter | Organic extract of PM2.5: 5 μg/ml | 48 h | Human lung cancer cell line (A549 cells) | |
| Obtained from a biomass power plant | 100 μg/ml | 5 weeks | Human bronchial epithelial cell line (BEAS-2B cells) | |
| Collected at Shanghai, China in four seasons using glass fiber filter | 20, 40, 60, 80, 100 μg/ml | 24 h | Human bronchial epithelial cell line (BEAS-2B cells) | |
| Collected at Beijing, China, from December 2016 to February 2017 using glass fiber filter | 2.5, 10, 20 mg/kg | Intratracheal instillation | 8-week-old male BALB/c mice | ( |
| Bought from NIST, USA (the product label: SRM 1648a) | 0.4 mg/m3 | Dynamic inhalation exposure using the exposure chambers and aerosol generator | 8-week-old C57BL/6 mice | ( |
Figure 2Potential regulatory routes of PM2.5 in EMT. PM2.5 might function as an EMT initiator by activating TGF-β/SMAD2/3, NF-κB, ERK, Akt, and mediating cytoskeleton rearrangement via ROS. In addition to epigenetic mechanisms such as lncRNAs, miRNAs, and DNA methylation regulation, HMGB1-RAGE, Shh, SMAD1, Wnt3a/β-catenin, and Notch pathways have also been originally validated as effector signaling of PM2.5 in the process of EMT. ACLY might act as a key metabolic modulator in PM2.5-induced EMT. Autophagy following PM2.5-ROS can also promote EMT. Specific components within PM2.5 might be EMT promoters, as PAHs can initiate EMT via AHR/CYP1A1 signaling, and Ca2+ ions might function by activating Ca2+ signaling. EMT, epithelial-mesenchymal transition; TGF-β, transforming growth factor β; ERK, extracellular signal-regulated protein kinase; ROS, reactive oxygen species; RAGE, receptor for advanced glycation end-products; Shh, sonic hedgehog; ACLY, ATP citrate lyase; PAHs, polyaromatic hydrocarbons; AHR, aryl hydrocarbon receptor.